Omega Pharma

• Profile
• Address
• Group structure
• History
• Vision and strategy
• Board & management

Brands

• Brand strategy
• Core Categories
• Star brands

Jobs

Other info

• Press releases
• News archive
• Illustrations
• Links
• Glossary

Board and management

 

 

Omega Pharma has two formal director and management bodies: the Board of Directors and the Executive Committee.

  

Board of directors

• Lucas Laureys NV (permanent representative: Mr. Lucas Laureys), independent director - (Mandate until ASM that takes place in 2010. The ASM of 5 May 2008 will receive the proposal to transfer his mandate to Lucas Laureys NV)
  
• Mercuur Consult NV, independent director as of 13 May 2007 (represented by Mr. Jan Boone, permanent representative) (Mandate until the ASM that takes place in 2010)
  
• Mr. Benoit Graulich, independent director (Mandate until the ASM that takes place in 2010)
  
• Mr. Jean-Louis Duplat, independent director (Mandate until the ASM that takes place in 2008. At the ASM of 5 May 2008, it will be proposed to prolong this mandate until the ASM that takes place in 2010)
• Mr. Marc Coucke, executive director (Mandate until the ASM that takes place in 2011)
  
• Couckinvest NV, executive director (represented by Mr. Marc Coucke, permanent representative) (Mandate until AV that takes place in 2011)
  
• Sam Sabbe BVBA, executive director - represented by Mr. Sam Sabbe, permanent representative - (Mandate until ASM that takes place in 2011)
  

Audit Committee - Chairman: Mercuur Consult NV (represented by Mr. Jan Boone) - members: Lucas Laureys NV (represented by Mr. Lucas Laureys), Mr. Benoit Graulich and Mr. Jean-Louis Duplat

 

Appointment and Remuneration Committee - Chairman: Mr. Benoit Graulich - members: Mr. Jean-Louis Duplat, Lucas Laureys NV (represented by Mr. Lucas Laureys) and Mercuur Consult NV (represented by Mr. Jan Boone).

 

Executive committee : 

• Couckinvest NV, represented by Marc Coucke, Chief Executive Officer (CEO)
• Georges De Vos, Chief Operating Officer (COO)
• M.D.S. BVBA, represented by Mario Debel, Head of Marketing & Innovation
• BDS Management BVBA, represented by Barbara De Saedeleer, Chief Financial Officer (CFO)
• Sam Sabbe BVBA, represented by Sam Sabbe, Chief Strategy Officer (CSO)
• Jan Cassiman BVBA, represented by Jan Cassiman, Head of Business Development 

For more information: Investors Corner/Corporate Governance.